Lantheus Holdings, Inc. (LNTH)
67.17
-0.17
(-0.25%)
USD |
NASDAQ |
Dec 30, 16:00
67.17
0.00 (0.00%)
After-Hours: 16:27
Lantheus Holdings EPS Diluted (Quarterly): 0.4104 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| Align Technology, Inc. | 0.7837 |
| Integra LifeSciences Holdings Corp. | -0.0704 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.77M |
| Revenue (Quarterly) | 384.01M |
| Total Expenses (Quarterly) | 356.24M |
| Enterprise Value | 4.703B |
| Gross Profit Margin (Quarterly) | 57.91% |
| Profit Margin (Quarterly) | 7.23% |
| Earnings Yield | 3.54% |
| Operating Earnings Yield | 7.33% |
| Normalized Earnings Yield | 5.281 |